Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy

Dewhirst, 2017, Transport of drugs from blood vessels to tumour tissue, Nat. Rev. Canc., 17, 738, 10.1038/nrc.2017.93 Goel, 2011, Normalization of the vasculature for treatment of cancer and other diseases, Physiol. Rev., 91, 1071, 10.1152/physrev.00038.2010 Nagy, 2010, Heterogeneity of the tumor vasculature, Semin. Thromb. Hemost., 36, 321, 10.1055/s-0030-1253454 Martin, 2016, Reengineering the tumor microenvironment to alleviate hypoxia and overcome cancer heterogeneity, Cold Spring Harbor Perspect. Med., 6 Bristow, 2008, Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability, Nat. Rev. Canc., 8, 180, 10.1038/nrc2344 Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819 Gacche, 2015, Compensatory angiogenesis and tumor refractoriness, Oncogenesis, 4, e153, 10.1038/oncsis.2015.14 Jain, 2006, Lessons from phase III clinical trials on anti-VEGF therapy for cancer, Nature clinical practice, Oncology, 3, 24 Cooke, 2012, Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway, Cancer Cell, 21, 66, 10.1016/j.ccr.2011.11.024 Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021 Keskin, 2015, Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2, Cell Rep., 10, 1066, 10.1016/j.celrep.2015.01.035 Paez-Ribes, 2009, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, 15, 220, 10.1016/j.ccr.2009.01.027 Al-Abd, 2017, Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies - a review, J. Adv. Res., 8, 591, 10.1016/j.jare.2017.06.006 Huang, 2015, Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution, Int. J. Clin. Exp. Med., 8, 8369 Borras, 2015, The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis, Radiotherapy and oncology, J. Eur. Soc. Ther. Radiol. Oncol., 116, 38, 10.1016/j.radonc.2015.04.018 Garcia-Barros, 2003, Tumor response to radiotherapy regulated by endothelial cell apoptosis, Science, 300, 1155, 10.1126/science.1082504 Potiron, 2013, Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer, PLoS One, 8, 10.1371/journal.pone.0084076 Pink, 2012, Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery, PLoS One, 7, 10.1371/journal.pone.0033760 Patel, 2013, Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues, Cancer Chemother. Pharmacol., 72, 127, 10.1007/s00280-013-2176-z Kim, 2017, Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery, Cancer Lett., 403, 339, 10.1016/j.canlet.2017.06.035 Qayum, 2012, Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo, Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res., 18, 161, 10.1158/1078-0432.CCR-11-1413 Ma, 2001, AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology, Med. Phys., 28, 868, 10.1118/1.1374247 Noblet, 2014, Underestimation of dose delivery in preclinical irradiation due to scattering conditions, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology, Off. J. Ital. Assoc. Biomed. Phys., 30, 63 Gaustad, 2012, Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts, BMC Canc., 12, 388, 10.1186/1471-2407-12-388 Mendel, 2003, In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship, Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res., 9, 327 Brooks, 2012, Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer, Radiat. Oncol., 7, 154, 10.1186/1748-717X-7-154 Saggar, 2013, Use of molecular biomarkers to quantify the spatial distribution of effects of anticancer drugs in solid tumors, Mol. Cancer Ther., 12, 542, 10.1158/1535-7163.MCT-12-0967 Davies Cde, 2004, Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts, Cancer Res., 64, 547, 10.1158/0008-5472.CAN-03-0576 Kalofonos, 1990, Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation, Cancer Res., 50, 159 Barrett, 2007, MRI of tumor angiogenesis, J. Magn. Reson. Imaging : JMRI, 26, 235, 10.1002/jmri.20991 Supiot, 2018, Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study, Oncotarget, 9, 10005, 10.18632/oncotarget.24234 Debbage, 2000, Vascular permeability and hyperpermeability in a murine adenocarcinoma after fractionated radiotherapy: an ultrastructural tracer study, Histochem. Cell Biol., 114, 259, 10.1007/s004180000192 Maeda, 2017, Vivo imaging reveals significant tumor vascular dysfunction and increased tumor hypoxia-inducible factor-1alpha expression induced by high single-dose irradiation in a pancreatic tumor model, Int. J. Radiat. Oncol. Biol. Phys., 97, 184, 10.1016/j.ijrobp.2016.09.005 Chen, 2009, Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors, Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res., 15, 1721, 10.1158/1078-0432.CCR-08-1471 Lan, 2013, Ablative hypofractionated radiotherapy normalizes tumor vasculature in lewis lung carcinoma mice model, Radiat. Res., 179, 458, 10.1667/RR3116.1 Chauhan, 2013, Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels, Nat. Commun., 4, 2516, 10.1038/ncomms3516 Lunt, 2008, Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis, Future Oncol., 4, 793, 10.2217/14796694.4.6.793 Chen, 2013, Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway, Int. J. Radiat. Oncol. Biol. Phys., 86, 777, 10.1016/j.ijrobp.2013.02.036 Winkler, 2004, Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases, Cancer Cell, 6, 553 Dias Moura Prazeres, 2017, Pericytes are heterogeneous in their origin within the same tissue, Dev. Biol., 427, 6, 10.1016/j.ydbio.2017.05.001 Holm, 2018, Microvascular mural cell organotypic heterogeneity and functional plasticity, Trends Cell Biol., 28, 302, 10.1016/j.tcb.2017.12.002 Berthiaume, 2018, Dynamic remodeling of pericytes in vivo maintains capillary coverage in the adult mouse brain, Cell Rep., 22, 8, 10.1016/j.celrep.2017.12.016 Hill, 2015, Regional blood flow in the normal and ischemic brain is controlled by arteriolar smooth muscle cell contractility and not by capillary pericytes, Neuron, 87, 95, 10.1016/j.neuron.2015.06.001 Hamdan, 2014, Blocking SDF-1alpha/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors, Mol. Cancer Ther., 13, 483, 10.1158/1535-7163.MCT-13-0447